Corvus Pharmaceuticals Inc buy Jefferies Financial Group Inc.
Start price
22.01.26
/
50%
€21.55
Target price
22.01.27
-
Performance (%)
-42.83%
Price
18.03.26
€13.06
Summary
This prediction is currently active. Massive losses of -42.83% have been the result for the BUY prediction by Jefferies_Financial_. This prediction currently runs until 22.01.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corvus Pharmaceuticals Inc | -7.112% | -7.112% |
| iShares Core DAX® | -2,12 % | -8,18 % |
| iShares Nasdaq 100 | -1,13 % | 0,91 % |
| iShares Nikkei 225® | -0,66 % | -6,26 % |
| iShares S&P 500 | -1,26 % | -1,00 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for CRVS provided by MarketBeat